INTRALESIONAL RITUXIMAB SUPPLEMENTED WITH AUTOLOGOUS SERUM IN RELAPSED CD20+ INDOLENT LYMPHOMAS OF THE CONJUNCTIVA: ACTIVITY AND SAFETY RESULTS OF THE “IRIS” TRIAL

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.180-181
Main Authors: Ferreri, A.J., Sassone, M., Miserocchi, E., Govi, S., Cecchetti, C., Corti, M.E., Calimeri, T., Perrone, S., Mappa, S., Ponzoni, M., Modorati, G.
Format: Article
Language:English
Subjects:
CD20 antigen
Conjunctiva
Immunotherapy
Monoclonal antibodies
Rituximab
Targeted cancer therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.137_2629